Page 9 | Certara

Publication

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…

CertaraNovember 5, 2025

Press Release

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara has released TFL studio, a module in its cloud-native PK/PD software, Phoenix Cloud, to…

CertaraNovember 4, 2025

On-Demand Webinar

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…

CertaraNovember 3, 2025

Blog

Empowering the PK Community: Insights from the Phoenix® User Events

Explore insights from the Phoenix User Events in Europe, where experts shared innovations in automation,…

CertaraNovember 3, 2025

Blog

How To Design a Case Report Form | 7 Best Practice Steps

Discover how to design a case report form with our 7 best practices: improve data…

CertaraNovember 3, 2025

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

CertaraOctober 31, 2025

Press Release

Certara to Participate in Upcoming Investor Conferences

Certara announced that Company management will participate in upcoming investor conferences. Learn more in the…

CertaraOctober 31, 2025

Press Release

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.

CertaraOctober 30, 2025

On-Demand Webinar

In silico Safety and Toxicology assessment: ToxStudio®

Discover how Certara’s ToxStudio align with FDA’s roadmap to reduce animal testing and transform preclinical…

CertaraOctober 30, 2025

Blog

At Certara, we’re proud to support WBUR, Boston’s NPR.

Certara supports public radio because NPR is aligned with our values and helps us spread…

CertaraOctober 29, 2025

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Certara Automates Scientific Workflows with Phoenix® Cloud

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Empowering the PK Community: Insights from the Phoenix® User Events

How To Design a Case Report Form | 7 Best Practice Steps

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Certara to Participate in Upcoming Investor Conferences

Certara Expands Biosimulation Market with AI-Driven QSP Platform

In silico Safety and Toxicology assessment: ToxStudio®

At Certara, we’re proud to support WBUR, Boston’s NPR.

Newsletter sign up

Quick links

Solutions

Contact